Adverse Impact of Bleeding on Prognosis in Patients With Acute Coronary Syndromes

Keywords

Medicine, Hazard ratio, Internal medicine, Acute coronary syndrome, Unstable angina

References

• Benefits and Risks of the Combination of Clopidogrel and Aspirin in Patients Undergoing Surgical Revascularization for Non–ST-Elevation Acute Coronary Syndrome: The Clopidogrel in Unstable angina to prevent Recurrent ischemic Events (CURE) TrialLucian W. Pye — 2004
• Comparison of two transfusion strategies after elective operations for myocardial revascularization.Robert G. Johnson, Robert L. Thurer, Margot S. Kruskall — 1992
• A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group.Paul C. Hébert, George A. Wells, Morris A. Blajchman — 1999
• The implications of blood transfusions for patients with non-ST-segment elevation acute coronary syndromes: results from the CRUSADE National Quality Improvement Initiative.Xin Yang, Karen P. Alexander, Anita Y. Chen — 2005
• EFFECTS OF CLOPIDOGREL IN ADDITION TO ASPIRIN IN PATIENTS WITH ACUTE CORONARY SYNDROMES WITHOUT ST-SEGMENT ELEVATIONThe Clopidogrel in Unstable Angina to Prevent Recurrent Events Trial Investigators — 2001
• Impact of bleeding severity on clinical outcomes among patients with acute coronary syndromes.Sunil V. Rao, Kristi O’Grady, Karen S. Pieper — 2005
• Impact of age on management and outcome of acute coronary syndrome: observations from the Global Registry of Acute Coronary Events (GRACE).Álvaro Avezum, Márcia Makdisse, Frederick A. Spencer — 2005
• A comparison of the clinical impact of bleeding measured by two different classifications among patients with acute coronary syndromes.Sunil V. Rao, Kristi O’Grady, Karen S. Pieper — 2006
• Is a low transfusion threshold safe in critically ill patients with cardiovascular diseases?Paul C. Hébert, Elizabeth Yetisir, Claudio M. Martin — 2001
• Use of low-molecular-weight heparins in the management of acute coronary artery syndromes and percutaneous coronary intervention.Graham C. Wong, Robert P. Giugliano, Elliott M. Antman — 2003
• Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patientsAntiplatelet Trialists Collaboration — 2002
• Magnitude of and Risk Factors for In-Hospital and Postdischarge Stroke in Patients With Acute Coronary Syndromes: Findings From a Global Registry of Acute Coronary EventsAndrzej Budaj, Katarzyna Flasińska, Joel M. Gore — 2005
• Blood transfusion in elderly patients with acute myocardial infarction.W.C. Wu, Saif S. Rathore, Y. Wang — 2001
• Predictors of major bleeding in acute coronary syndromes: the Global Registry of Acute Coronary Events (GRACE).Mauro Moscucci — 2004
• Predictors of outcome in patients with acute coronary syndromes without persistent ST-segment elevation. Results from an international trial of 9461 patients. The PURSUIT Investigators.Eric Boersma, Karen S. Pieper, Ewout W. Steyerberg — 2000
• Association of Hemoglobin Levels With Clinical Outcomes in Acute Coronary SyndromesMarc S. Sabatine, David A. Morrow, Robert P. Giugliano — 2005
• The way I see it: House officers need formal career developmentAndy M. Connor — 2002
• A prospective, randomized trial limiting perioperative red blood cell transfusions in vascular patients.Ruth L. Bush, William C. Pevec, James W. Holcroft — 1997
• Routine vs selective invasive strategies in patients with acute coronary syndromes: a collaborative meta-analysis of randomized trials.Shamir R. Mehta, C.P. Cannon, Keith A.A. Fox — 2005
• Randomized evaluation of the safety and efficacy of enoxaparin versus unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes receiving the glycoprotein IIb/IIIa inhibitor eptifibatide.Shaun G. Goodman, David Fitchett, Paul W. Armstrong — 2003

Cited by

• Novel approaches for preventing or limiting events (Naples) III trial: randomized comparison of bivalirudin versus unfractionated heparin in patients at increased risk of bleeding undergoing transfemoral elective coronary stenting.Carlo Briguori, Gabriella Visconti, Amelia Focaccio — 2015
• Gender differences in anticoagulation and antithrombotic therapy.Ursula Rauch — 2012
• The ECG as decision support in STEMI.Maria Sejersten Ripa — 2012
• Safety and efficacy of bivalirudin with and without glycoprotein IIb/IIIa inhibitors in patients with acute coronary syndromes undergoing percutaneous coronary intervention 1-year results from the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) trial.Harvey D. White, E. Magnus Ohman, A. Michael Lincoff — 2008
• The Leipzig prospective vascular ultrasound registry in radial artery catheterization: impact of sheath size on vascular complications.Madlen Uhlemann, Sven Möbius‐Winkler, Meinhard Mende — 2012
• Contribution of bleeding and thromboembolic events to in-hospital mortality among patients with thrombocytopenia treated with heparin.Christina Skrikas — 2009
• Transradial versus transfemoral approach for percutaneous coronary proceduresPedro María Pérez Castroviejo — 2009
• A risk score to predict bleeding in patients with acute coronary syndromes.V.F. Litvin — 2010
• The frequency of vascular complications associated with the use of vascular closure devices varies by indication for cardiac catheterization順子 長谷川 — 2011
• Radial Artery Occlusion After Transradial Approach to Cardiac Catheterizationいずみ 福田, 直美 肥塚, 由美子 大久保 — 2015
• Bivalirudin vs heparin with or without tirofiban during primary percutaneous coronary intervention in acute myocardial infarction: the BRIGHT randomized clinical trial.Alistair Inglis — 2015
• Incremental Value of Platelet Reactivity Over a Risk Score of Clinical and Procedural Variables in Predicting Bleeding After Percutaneous Coronary Intervention via the Femoral Approach: Development and Validation of a New Bleeding Risk ScoreSilvia Baratta — 2015
• An anticoagulant too good to be true for revascularisation.Freek W.A. Verheugt — 2016
• Efficacy of Ex Vivo Autologous and In Vivo Platelet Transfusion in the Reversal of P2Y12 Inhibition by Clopidogrel, Prasugrel, and Ticagrelor: The APTITUDE StudyStephen O’Connor, Julien Amour, Anne Mercadier — 2015
• Management of bleeding in patients treated with direct oral anticoagulantsLidia Román González — 2016
• Ticagrelor with aspirin or alone in high-risk patients after coronary intervention: Rationale and design of the TWILIGHT study.A. Bogerd — 2016
• Impact of in-hospital major bleeding on late clinical outcomes after primary percutaneous coronary intervention in acute myocardial infarction the HORIZONS-AMI (Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction) trial.Jung-Won Suh, Roxana Mehran, Bimmer E. Claessen — 2011
• Clopidogrel and proton pump inhibitors: influence of pharmacological interactions on clinical outcomes and mechanistic explanations.Udaya S. Tantry, Dean J. Kereiakes, Paul A. Gurbel — 2011
• [Gastrointestinal bleeding in patients undergoing primary angioplasty for acute myocardial infarction: incidence, risk factors and prognosis].Mehmet Ergelen, Hüseyin Uyarel, Özer Soylu — 2010
• Antiplatelet therapy: Clopidogrel plus PPIs—a dangerous combination?José Luis Ferreiro, Dominick J. Angiolillo — 2009

Related papers

• The Application of High-loading-dose of Clopidogrel in Acute Coronary SyndromeKeng Wu — 2008
• OUTCOMES IN PATIENTS TREATED WITH TICAGRELOR OR CLOPIDOGREL AFTER ACUTE CORONARY SYNDROME: EXPERIENCES FROM SWEDEHEART REGISTRYAnders Sahlén, Christoph Varenhorst, Bo Lagerqvist — 2016
• Progress of the Application of High Loading-and Maintenance-dose Clopidogrel in Acute Coronary SyndromeRen Zhi-liang — 2012
• C0258 Importance of the effect of aspirin in patients with acute coronary syndrome who have an adequate antiplatelet effect of clopidogrelJuana Vallés, Isabel Martins Madrid, Antonio Moscardó — 2012
• CHOICE OF ANTITHROMBOTIC THERAPY FOLLOWING ACUTE CORONARY SYNDROMEЕ. С. Енисеева — 2013
• Advances in antiplatelet technologies to improve cardiovascular disease morbidity and mortality: a review of ticagrelorEstella M. Davis, Jon T. Knezevich, Robyn Teply — 2013
• AS-2: Significance of Slow-Response to Clopidogrel Assessed by a Point-of-Care Assay in Acute Coronary Syndrome Patients Undergoing Coronary StentingKyounghoon Lee, Seung‐Hwan Lee, Young-Jin Youn — 2009
• ▼Clopidogrel and acute coronary syndrome2002
• Changes and relations between serum soluble CD40L and TNF-α in patients of actue coronary syndromeYuping Sun — 2007